Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1747-597X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review ; volume:17 ; number:1 ; day:26 ; month:8 ; year:2022 ; pages:1-20 ; date:12.2022
Substance abuse treatment, prevention, and policy ; 17, Heft 1 (26.8.2022), 1-20, 12.2022
- Creator
-
Pijl, Em M.
Alraja, Abeer
Duff, Elsie
Cooke, Carol
Dash, Stephen
Nayak, Nichole
Lamoureux, Jesse
Poulin, Ginette
Knight, Erin
Fry, Ben
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13011-022-00463-5
- URN
-
urn:nbn:de:101:1-2022111309122154149595
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pijl, Em M.
- Alraja, Abeer
- Duff, Elsie
- Cooke, Carol
- Dash, Stephen
- Nayak, Nichole
- Lamoureux, Jesse
- Poulin, Ginette
- Knight, Erin
- Fry, Ben
- SpringerLink (Online service)
Other Objects (12)
Better agonist for the opioid receptors
Alcohol use in opioid agonist treatment
Interim opioid agonist treatment for opioid addiction: a systematic review
![Agonist-selektive Phosphorylierung und Dephosphorylierung des μ-Opioid-Rezeptors [My-Opioid-Rezeptors]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Agonist-selektive Phosphorylierung und Dephosphorylierung des μ-Opioid-Rezeptors [My-Opioid-Rezeptors]
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
Untersuchungen zur Wirkung des κ-Opioid-Rezeptor-Agonisten [Kappa-Opioid-Rezeptor-Agonisten] EMD 61 753 und Methylprednisolon auf Lymphozyten der Ratte
Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review
Antiinflammatorische Effekte eines neuen kappa-Opioid-Rezeptor Agonisten (WOL071-007)
Better agonist for the opioid receptors
Alcohol use in opioid agonist treatment
Interim opioid agonist treatment for opioid addiction: a systematic review
Agonist-selektive Phosphorylierung und Dephosphorylierung des μ-Opioid-Rezeptors [My-Opioid-Rezeptors]
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
Untersuchungen zur Wirkung des κ-Opioid-Rezeptor-Agonisten [Kappa-Opioid-Rezeptor-Agonisten] EMD 61 753 und Methylprednisolon auf Lymphozyten der Ratte
Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review
Antiinflammatorische Effekte eines neuen kappa-Opioid-Rezeptor Agonisten (WOL071-007)
Better agonist for the opioid receptors
Alcohol use in opioid agonist treatment
Interim opioid agonist treatment for opioid addiction: a systematic review
Agonist-selektive Phosphorylierung und Dephosphorylierung des μ-Opioid-Rezeptors [My-Opioid-Rezeptors]
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
Untersuchungen zur Wirkung des κ-Opioid-Rezeptor-Agonisten [Kappa-Opioid-Rezeptor-Agonisten] EMD 61 753 und Methylprednisolon auf Lymphozyten der Ratte
Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review